We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Isabel Ely, PhD

Isabel Ely, PhD profile page

Science Writer

 at Technology Networks

Isabel joined Technology Networks in June 2024 as a Science Writer and Editor after completing her PhD in human physiology from the University of Nottingham. Her research focused on the importance of dietary protein and exercise in maximizing muscle health in advancing age. She also holds a BSc in exercise and sport sciences from the University of Exeter and an MRes in medicine and health from the University of Nottingham.


Education

University of Nottingham  

University of Exeter  


Areas of Expertise

Skeletal muscle
Exercise physiology
Sarcopenia
Dietary protein
Physical (in)activity

Got a Question for Isabel Ely, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly.



Published Content
Total: 21
Spirals of protein with molecular structure "falling" out
Industry Insight

Enhancing Biopharmaceutical Efficiency: Intact-Level PTM Identification and Charge Variant Analysis

In this interview, Technology Networks spoke with Dr. Jingwen Ding, senior applications scientist at SCIEX, to understand how charge variant analysis and advanced technologies can enhance biopharmaceutical workflows.
A robot arm holding a gear touching a human hand also holding a gear
Industry Insight

The Role of Automation in Industrializing Cell Therapy Manufacturing

Technology Networks spoke to Dr. Dan Strange, CTO at Cellular Origins, to discuss how integrating proven tools and technologies, such as automation, helps cell therapy companies scale up production.
Paper file documents
Industry Insight

Enhancing Data Provenance To Safeguard Biomedical Research Integrity

In this interview, Dr. Jonathan Jacobs, who leads ATCC’s Sequencing & Bioinformatics Center, discusses how data provenance influences data integrity in scientific research and how a lack of standardization can lead to issues like data poisoning.
Aerial view of forest with conical flask embedded into it.
Industry Insight

Sustainability Programs Maximize Lifespan for Laboratory Instrumentation

Technology Networks recently spoke with Aimee Whaley from Agilent Technologies to learn how Agilent is optimizing resources through waste reduction and equipment refurbishment programs.
Lab bench with data falling down the page and titled data compliance within the laboratory
Infographic

Data Compliance Within the Laboratory

Data powers scientific discovery and directs new areas of research. Download this infographic to learn more about the importance of data compliance, differing data compliance regulations and how the compliance process can be simplified.
Brain made from leaves
Industry Insight

New Biobased Film Aids Sustainability Challenges Within the Biopharma Industry

We sat down with Dr. John Puglia, senior director of research and development at Thermo Fisher, to learn more about their new biobased films and other sustainability initiatives.
Whole and halved strawberries
Industry Insight

New Developments in Analytical Systems May Aid the “Fight” Against PFAS

Technology Networks recently spoke with Dr. Holly Lee and Dr. Craig Butt from SCIEX to learn more about the analytical challenges of detecting PFAS and SCIEX’s 7500+ system to aid developments in mass spectrometry.
Artificial intelligence brain on computerized network background
Industry Insight

The Adoption of AI: Critical Concerns in the Life Sciences

In this interview, Dr. Becky Upton discusses the key findings of a recent survey conducted by the Pistoia Alliance regarding the use of AI in life sciences and the main hurdles preventing wider adoption of AI in pharma.
Multiple cells with orange nucleus
Industry Insight

How New Technology Can Leverage Single-Cell Omics Techniques

In this interview, we spoke to Jason Koth, product management lead at Scale Biosciences, to learn more about their new ScalePlex technology for leveraging and overcoming current limitations within single-cell genomics.
Macrophages attacking a cancer cell
Industry Insight

Attacking Cancer Through Activating “Big Eaters” of the Immune System

In this interview, Technology Networks spoke with Dr. Roy Maute, co-founder and CEO of Pheast Therapeutics, to learn about macrophage checkpoint therapies and the potential they hold for cancer treatment.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter